Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127429041 | 12742904 | 1 | I | 20160907 | 0 | 20160914 | 20160914 | DIR | US-FDA-350588 | FDA-CTU | 49.92 | YR | F | N | 51.75000 | KG | 20160914 | N | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127429041 | 12742904 | 1 | PS | LISINOPRIL. | LISINOPRIL | 1 | Oral | Y | D | 0 | 90 | DF | COATED TABLET | ||||||
| 127429041 | 12742904 | 3 | C | CLOPIDOGREL BISULFATE. | CLOPIDOGREL BISULFATE | 1 | 0 | ||||||||||||
| 127429041 | 12742904 | 5 | C | ASPIRIN. | ASPIRIN | 1 | 0 | ||||||||||||
| 127429041 | 12742904 | 7 | C | ATORVASTATIN | ATORVASTATIN | 1 | 0 | ||||||||||||
| 127429041 | 12742904 | 9 | C | METOPROLOL SUCCINATE. | METOPROLOL SUCCINATE | 1 | 0 | ||||||||||||
| 127429041 | 12742904 | 11 | C | GABAPENTIN. | GABAPENTIN | 1 | 0 | ||||||||||||
| 127429041 | 12742904 | 13 | C | PREMARIN | ESTROGENS, CONJUGATED | 1 | 0 | ||||||||||||
| 127429041 | 12742904 | 15 | C | MONTELUKAST SODIUM. | MONTELUKAST SODIUM | 1 | 0 | ||||||||||||
| 127429041 | 12742904 | 17 | C | TEMAZEPAM. | TEMAZEPAM | 1 | 0 | ||||||||||||
| 127429041 | 12742904 | 19 | C | IBUPROFEN. | IBUPROFEN | 1 | 0 | ||||||||||||
| 127429041 | 12742904 | 20 | SS | MULTIVITAMIN | VITAMINS | 1 | 0 | ||||||||||||
| 127429041 | 12742904 | 22 | C | FISH OIL | FISH OIL | 1 | 0 | ||||||||||||
| 127429041 | 12742904 | 24 | C | VITAMIN D3 | CHOLECALCIFEROL | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127429041 | 12742904 | 1 | Acute myocardial infarction |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127429041 | 12742904 | LT |
| 127429041 | 12742904 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127429041 | 12742904 | Angioedema | |
| 127429041 | 12742904 | Cold sweat | |
| 127429041 | 12742904 | Dyspnoea | |
| 127429041 | 12742904 | Pallor | |
| 127429041 | 12742904 | Speech disorder | |
| 127429041 | 12742904 | Stridor |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127429041 | 12742904 | 1 | 20160124 | 20160907 | 0 |